Shin Yeu Ong

机构：Singapore General Hospital, City of Hope · ORCID：0000-0003-0192-6975

发表论文 55 篇 · 总被引 977 次 · h-index 13

代表论文

Odronextamab monotherapy in patients with relapsed/refractory diffuse large B cell lymphoma: primary efficacy and safety analysis in phase 2 ELM-2 trial (2025 · Nature Cancer · 被引 52)
An ex vivo platform to guide drug combination treatment in relapsed/refractory lymphoma (2022 · Science Translational Medicine · 被引 39)
Bendamustine lymphodepletion is a well‐tolerated alternative to fludarabine and cyclophosphamide lymphodepletion for axicabtagene ciloleucel therapy for aggressive B‐cell lymphoma (2023 · American Journal of Hematology · 被引 35)
Aggressive T‐cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management (2024 · American Journal of Hematology · 被引 29)
PD-1 Blockade before Autologous Stem Cell Transplantation Improves Outcomes in Relapsed/Refractory Classic Hodgkin Lymphoma: Results from a Multicenter Cohort (2023 · Blood · 被引 13)
Efficacy of Brentuximab Vedotin Maintenance Therapy Following Autologous Stem Cell Transplantation in Patients with Relapsed/Refractory Classical Hodgkin Lymphoma with and without Pre-Transplant Exposure to Novel Agents (2023 · Blood · 被引 9)